ReviewLa Radiologia medica2026
Radiologic exposomics: imaging the environmental imprint on cancer for precision oncology.
Review in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Environmental exposures-such as airborne pollutants, metals, and urban stressors-contribute to cancer development and progression, yet their downstream biological effects remain difficult to characterize in vivo. Quantitative medical imaging may help fill this gap. Radiomics, in particular, offers access to tissue-level patterns shaped by chronic injury and microenvironmental remodeling. In this review, we discuss the rationale for linking geospatial exposure assessment with CT- and MRI-derived imaging biomarkers and outline how radiologic features may reflect processes associated with long-term environmental stress, including oxidative damage, inflammation, and metabolic or immune dysregulation. We also summarize epidemiologic evidence across major cancer types to contextualize where imaging-exposure integration is most plausible. A methodological workflow is presented, covering exposure assignment, imaging standardization, feature extraction, and strategies for harmonizing and modeling high-dimensional exposomic and radiomic data. Considerations related to confounding, data governance, and equity are also addressed, as these factors are integral to responsible implementation. Viewed in this light, imaging can be interpreted as an intermediate phenotype of the exposome-capturing aspects of tumor and peritumoral biology influenced by external stressors. This perspective may expand the role of radiology in precision oncology and generate new hypotheses about how environmental conditions shape cancer biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.